PFIS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
PFIS is not a good buy right now for an impatient buyer. Despite a constructive technical setup, there are no Intellectia buy signals, near-term pattern stats lean mildly negative, and the latest quarter shows a sharp deterioration in earnings—making the risk/reward unattractive at the current pre-market price (~51.27).
Trend/structure: Bullish moving-average stack (SMA_5 > SMA_20 > SMA_200) indicates an established uptrend. Momentum: MACD histogram is positive (0.0836) and expanding, supportive of continued upside; RSI(6)=58.45 is neutral-to-slightly bullish (not overbought). Levels: Price is sitting just above the pivot (51.138). Immediate resistance is R1 52.846 then R2 53.9; supports are S1 49.43 then S2 48.376. Quant/pattern outlook: Similar-pattern model implies a modest downside bias (60% chance of -0.92% next day, -1.96% next week, -0.54% next month), which conflicts with the bullish MA/MACD backdrop.
Intellectia Proprietary Trading Signals
Technicals remain constructive (bullish MA alignment; MACD improving), which can support continuation if buyers defend the 51 pivot.
Revenue growth in 2025/Q3 (+5.27% YoY) suggests topline resilience.
Next earnings: 2026-02-12 (pre-market) could reset expectations if profitability normalizes.
2025/Q3 profitability deteriorated sharply: Net income down -451.53% YoY and EPS down -451.16% YoY, which is a major fundamental headwind.
No supportive news flow in the past week; no clear event-driven upside catalyst right now.
Intellectia signals are absent (no AI Stock Picker or SwingMax entry), reducing conviction for an immediate buy.
Short-term statistical outlook from similar candlestick patterns leans slightly negative.
Broader tape is risk-off pre-market (S&P 500 -0.4%).
Latest quarter: 2025/Q3. Revenue increased to $46.756M (+5.27% YoY), but profitability dropped sharply: net income $15.246M (-451.53% YoY) and EPS 1.51 (-451.16% YoY). This indicates weakening earnings quality/pressure versus the prior-year quarter despite revenue growth.
No analyst rating or price-target change data was provided, so there is no identifiable recent trend in Wall Street upgrades/downgrades. Pros (based on available data): constructive technical trend and revenue growth. Cons: severe YoY earnings deterioration and lack of near-term conviction signals.
